Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04181203
Title Combined Apalutamide, Radiotherapy, and LHRH Agonist in Prostate Cancer Patients After Prostatectomy (CARLHA-2)
Recruitment Recruiting
Gender male
Phase Phase III
Variant Requirements No

prostate adenocarcinoma


Gonadorelin + Radiotherapy

Apalutamide + Gonadorelin + Radiotherapy

Age Groups: senior | adult
Covered Countries FRA

Facility Status City State Zip Country Details
Clinique Claude Bernard Not yet recruiting Albi France Details
Institut de Cancérologie de l'Ouest Recruiting Angers France Details
Institut Bergonié Not yet recruiting Bordeau France Details
Centre Georges François LECLERC Recruiting Dijon France Details
Centre Hospitalier Emile ROUX Not yet recruiting Le Puy-en-Velay France Details
Centre Oscar Lambret Recruiting Lille France Details
Institut de Cancérologie de Montpellier Not yet recruiting Montpellier France Details
Centre Antoine Lacassagne Recruiting Nice France Details
Institut Jean Godinot Not yet recruiting Reims France Details
Centre Henri Becquerel Not yet recruiting Rouen France Details
Institut de Cancérologie de l'Ouest Recruiting Saint Herblain France Details
Institut de Cancérologie de la Loire Lucien Neuwirth Recruiting Saint-Priest-en-Jarez France Details
Institut de Cancérologie Paris Nord Not yet recruiting Sarcelles France Details
Centre Paul STRAUSS Not yet recruiting Strasbourg France Details
Clinique Pasteur - ONCORAD Not yet recruiting Toulouse France Details
*Shaded cells indicate that there was no data available from for the field